Health Care: Drugs

Vanda Pharmaceuticals Inc (VNDA: NASDAQ)

$15.5 -0.35 | -2.21%
10/25/16 - 03:06 PM ET
Company Profile
Price and Volume
Recent Price 15.85
52 Week High 18.00
52 Week Low 6.91
Avg. Daily Vol. (Mil) 0.87
Beta (3 year) 0.73
Share Related Items
Mkt Cap (Mil) 686.06
Shares Out (Mil) 43.28
Float (Mil) 36.20
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.90
Current Ratio 3.10
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 5.30
Price/Book 5.64
Price/Cash Flow -24.10
Per Share Data
Earnings -0.96
Sales 2.99
Book Value 2.81
Cash Flow -0.66
Business Summary
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of products for the treatment of central nervous system disorders. Its products include HETLIOZ, Fanapt, Trichostatin A, AQW051, and VLY-686.
General Information
2200 Pennsylvania Avenue NW
Suite 300 E
Washington, DC 20037
Industry : Drugs
Sector: Health Care
Employees: 118
CEO: Dr. Mihael Hristos Polym
Short Interest
Current Month (Mil) 2.74
Previous Month (Mil) 2.71
Short Interest Ratio (Days) 2.60
Management Effectiveness
Return on Equity n.a.
Return on Assets -20.40
Return on Investments -33.90
Gross Margin 81.40
EBIT Margin -31.80
Profit Margin -31.80

Portfolios with VNDA

Latest VNDA Headlines from TheStreet

More Financial News for VNDA

Press Releases for VNDA

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter